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A Selective Sweep on a Deleterious Mutation
in CPT1A in Arctic Populations
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Arctic populations live in an environment characterized by extreme cold and the absence of plant foods for much of the year and are
likely to have undergone genetic adaptations to these environmental conditions in the time they have been living there. Genome-wide
selection scans based on genotype data from native Siberians have previously highlighted a 3 Mb chromosome 11 region containing
79 protein-coding genes as the strongest candidates for positive selection in Northeast Siberians. However, it was not possible to deter-
mine which of the genes might be driving the selection signal. Here, using whole-genome high-coverage sequence data, we identified
the most likely causative variant as a nonsynonymous G>A transition (rs80356779; c.1436C>T [p.Pro479Leu] on the reverse strand) in
CPT1A, a key regulator of mitochondrial long-chain fatty-acid oxidation. Remarkably, the derived allele is associated with hypoketotic
hypoglycemia and high infant mortality yet occurs at high frequency in Canadian and Greenland Inuits and was also found at 68%
frequency in our Northeast Siberian sample. We provide evidence of one of the strongest selective sweeps reported in humans; this
sweep has driven this variant to high frequency in circum-Arctic populations within the last 6–23 ka despite associated deleterious
consequences, possibly as a result of the selective advantage it originally provided to either a high-fat diet or a cold environment.Siberia, where local temperatures occasionally drop below
70C in the winter and only animals are available for
consumption for much of the year, is one of the most
extreme habitats human populations have adapted to
since their dispersal out of Africa. A high basal metabolic
rate, low levels of serum lipids, and high blood pressure
are among the characteristics considered to be conse-
quences of adaptation in Siberian populations.1,2 In a
recent genome-wide SNP genotype study of 200 Siberian
individuals,3 the strongest signals of positive selection
detected by tests for haplotype homozygosity and allele
differentiation mapped to a 3 Mb region containing 79
protein-coding genes at chr11: 66–69 Mb in Northeast
Siberian populations. Because of the limited density of
markers in the SNP data, it was impossible to pinpoint
the causative locus for the selection signal. Here, we
sequenced the genomes of 25 unrelated individuals from
the Chukchi, Eskimo, and Koryak populations (Figure S1,
available online) with a mean coverage of >403 by using
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Ethics Committee (HBREC.2011.01). We used these
sequence data to search for derived variants that are com-
mon in Northeast Siberians and rare or absent elsewhere.
We then applied sequence-diversity-, derived-allele-fre-
quency-, and haplotype-homozygosity-based methods to
identify the possible causative variant(s) driving the signal
and to estimate their age and strength of selection.
We applied QIAGEN’s Ingenuity Variant Analysis soft-
ware to 21,105,873 variants detected in 25 Northeast
Siberian samples by using a series of filtering steps. A
total of 14,183,704 variants with call quality and depth
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1000 Genomes data,4,5 Complete Genomics public ge-
nomes,6 and NHLBI Exome Sequencing Project data) and
retained 8,278 variants with >50% carrier frequency in
our Northeast Siberian sample. We applied additional
filters, excluding indel and substitution variants, and
retained 148 SNPs with nonreference allele frequency
>50%. Among these 148 SNPs (Table S2), we detected three
with a possible functional consequence predicted by their
location in exonic, promoter, or enhancer regions or
among phylogenetically conserved positions (phyloP
value < 103). Note that unrecognized regulatory regions
that might be under selection would not be detected by
these filters. Among these three mutations, two mapped
to the same chromosomal region (chr11: 68.5–68.7 Mb),
which lay within the previous candidate region of positive
selection in Siberian populations:3 one nonsynonymous
(c.1436C>T) mutation in carnitine palmitoyltransferase
I (CPT1A [MIM 600528]) and another in the promoter re-
gion of immunoglobulin mu binding protein 2 (IGHMBP2
[MIM 600502]; position 68,670,984). To investigate
whether one of these mutations could be the target of pos-
itive selection, we applied further neutrality tests and
explored the genetic variation in this region.
First, we searched genome-wide in the sequence data for
candidate regions under selection. We merged the 25
Northeast Siberian genomes with a control panel of 25 Eu-
ropean and 11 East Asian publicly available, high-coverage
Complete Genomics genomes (Personal Genomes Proj-
ect)6 (Table S3). The integrated haplotype score (iHS)
test7 confirmed our previous findings3 in that the largest
number of significant (here, top 1%) windows fell within
the chr11: 66–69 Mb region (Figure S2; Table S4). The
two top-ranking iHS windows mapped within the chr11:
66–69 Mb region, and the window containing CPT1A
ranked 45th among 13,035 genomic windows, whereas
the window containing IGHMBP2 was not significant
(Figure 1). In the control populations, neither of these
windows was significant.
Second, we performed genome-wide Tajima’s D8 scans,
which highlighted two windows with significantly nega-
tive D values in the chr11: 66–69Mb region (Figure 1; Table
S5). These twowindowsnarrowed the 3Mb selection candi-
date region to 400 kb (68.2–68.6 Mb), which contains five
protein-coding genes: low-density lipoprotein receptor-
related protein 5 (LRP5 [MIM 603506]), protein phos-
phatase 6, regulatory subunit 3 (PPP6R3 [MIM 610879]),
galanin (GAL [MIM 137035]), metallothionein-like 5,
testis-specific (MTL5 [MIM 604374]), and CPT1A. As with
iHS, the window containing IGHMBP2 was not significant
in the Tajima’s D scans. Also, the Tajima’s D statistic in the
400 kb region was not significantly different from the
genomic average in the control populations (Figures 1 and
S3). Thus, both iHS and Tajima’s D tests provided evidence
that the selection signal is restricted to Northeast Siberians
and favoredCPT1Aover IGHMBP2 as the target of selection.
To corroborate this conclusion, we considered the
derived site-frequency spectrum (SFS) in the region sur-The Americanrounding CPT1A against the background, allowing us to
study deviations from neutrality without the assumption
of mutation-drift equilibrium. In Northeast Siberians, the
SFS in the 68–69 Mb region shows an excess of low- and
high-frequency variants in comparison to the background
SFS of the whole genome, consistent with the expectation
under a selective sweep9,10 (see Figure S4). Moreover, we
investigated the pattern of linkage disequilibrium (LD) in
the 3 Mb region (chr11: 66–69 Mb) and found two distinct
LD blocks, one on each side of the c.1436C>T mutation,
within the region of 68.2–68.8 Mb (Figure S5). Such a
pattern is expected in the later stages of a selective sweep,
when the beneficial allele has reached a frequency of
>0.5.11,12 Therefore, the LD pattern provides further evi-
dence that the c.1436C>T mutation could be driving the
signal. However, the c.1436C>T mutation, which is also
frequent in other Arctic Inuits, has previously been associ-
ated with high infant mortality and hypoketotic hypogly-
cemia (carnitine palmitoyltransferase I deficiency [MIM
255120]) in Canadian Inuits, and its high frequency in
these populations has been described as a ‘‘paradox’’
(e.g., Greenberg et al.13).
To further explore the global distribution of c.1436C>T,
wemeasured its frequency in a global panel of modern and
ancient genomes and created a median-joining network of
the locus (Figure 2). In the modern samples, we found
c.1436C>T at 68% frequency in the Northeast Siberian
populations, but it was absent in other publicly available
genomes.4,5 In the ancient samples, the c.1436C>T muta-
tion was absent in both the c. 24-ka-old Mal’ta boy14 and
the c. 12.6-ka-old Clovis sample15 but was heterozygous
in the genome of the c. 4-ka-old Saqqaq Palaeo-Eskimo.17
Furthermore, either the c.1436C>T mutation or its associ-
ated haplotype was detected in a number of Canadian and
Greenlandic Pre-, Middle-, and Late-Dorset ancient-DNA
samples16 dating to the last 4 ka and had a combined fre-
quency of ~50% (Figure 2A; Table S7). The ancient-DNA
evidence shows that the c.1436C>T mutation has a mini-
mum age of c. 4 ka, whereas the ancient and modern
samples together suggest that its spread was restricted to
Eskimo-Aleutian and Northeast Siberian populations. The
geographic distribution of the haplotype from which the
c.1436C>T haplotype is derived was mainly restricted to
East Asia (Figure 2A). Notably, in contrast to the recent
finding that CPT1A was among the lipid-catabolism-
associated genes enriched with Neandertal-like sites,20
the c.1436C>T mutation occurs at the background of 27
other SNPs that are common in Siberians and rare or
absent elsewhere. None of these 28 SNPs (Table S7) shared
Neandertal or Denisovan ancestry.
Finally, we used different models to infer population
parameters from the data. Based on the observed genetic
diversity,8,21 LD,22 and multiple sequentially Markovian
coalescent,23 our estimates of the effective population
size, Ne, yielded a long-term average Ne of 3,000–5,000
and supported a constant-size model (Figure S6; Table S8).
In contrast, a bottleneck scenario, in which the c.1436C>TJournal of Human Genetics 95, 584–589, November 6, 2014 585
AB
Figure 1. Localization of Positive-Selection Signals within a 3 Mb Region on Chromosome 11
(A) A high concentration of significant iHS (top) and Tajima’s D (bottom) signals was found in a 3 Mb region (chr11: 66–69 Mb) in
Northeast Siberians. The results are shown in the context of the East Asian and European control populations. Pale gray lines highlight
the boundaries of each 200 kb window in the region. The horizontal black dotted line marks the threshold of 1% significance. The over-
lapping 400 kb region (chr11: 68.2–68.6 Mb) of significant results from both tests is highlighted by a bold black rectangle.
(B) The genome-wide selection scans show that the window containing CPT1A (chr11: 68.4–68.6 Mb), highlighted by the red dot in
the three plots, is significant in the Northeast Siberian populations, but not in the control populations (Europeans and East Asians).
The black dots are the significant data points in both iHS and Tajima’s D tests. Dotted lines show the significance thresholds of the
respective tests.mutation would have reached high frequencies from
standing variation by drift, was not supported because
the c.1436C>T mutation is absent in other global popula-
tions and the derived A allele in Northeast Siberians occurs
within a genomic region of unusually strong LD. Rather,586 The American Journal of Human Genetics 95, 584–589, Novembour findings suggest a recent origin of the c.1436C>T
mutation in Northeast Siberians.
Under the assumption that the c.1436C>T mutation
was the target of positive (directional) selection, we esti-
mated the mode of selection, selection strength (s), ander 6, 2014
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Figure 2. Geographic Distribution and
Network of the CPT1A c.1436C>T Muta-
tion and Its Associated Haplotype
(A) The c.1436C>T derived allele is
defined by the rs80356779 G>A muta-
tion and occurs with a frequency of 0.9,
0.875, and 0.5625 in Chukchi, Eskimo,
and Koryaks, respectively, but is absent
elsewhere (1000 Genomes Project,4,5 CG
public data,6 and Personal Genome Proj-
ect). We used three SNPs (rs10896365
A>G, rs80356779 G>A, and rs3794020
T>C) to define the haplotype GAT
(red, see B). The haplotype ancestral
to the c.1436C>T mutation (GGT) is
shown in black. The white node re-
presents all other haplotypes. Grey
shading that encompasses both the
white and black nodes refers to subjects
for whom information was only available
for rs80356779. The map shows the
geographic distribution of these haplo-
types. Haplotype data were drawn from
modern-DNA (blue font) and ancient-
DNA (red font) sources, including Chuk-
chi (CEK), Eskimo, and Koryaks (present
study); 1000 Genomes Project;4,5
Nunavut Inuit (NUN);13 Mal’ta (M’TA);14
Clovis (ANZ);15 Aleutian Islander (ALE);
Early, Middle, and Late Dorset (DOR)
(Table S10);16 Saqqaq (SQQ);17 and
Greenland Inuit (GIN).18
(B) The Haplotype Median Joining
Network was constructed from sequences
of the Northeast Siberians and control
populations (Europeans and East Asians)
on the basis of 848 SNPs present in
the 58,084 bp region (Table S6) surround-
ing c.1436C>T with the use of the
Network 4.612 package.19 The circles
are proportional to the frequency of
the shared haplotype. On the basis
of this network analysis, we chose two
SNPs (rs10896365 A>G and rs3794020
T>C) that defined the haplotype (black nodes) ancestral to the c.1436C>T mutation (red nodes). For visualization, some branches
in the figure are shortened (marked with break). The dashed lines represent likely recombination events.age of the c.1436C>T allele (time to the most recent com-
mon ancestor [TMRCA]) by using an approximate Bayesian
computation (ABC) method.24 We found strong evidence
in favor of selection from a de novo mutation P(SDN) ¼
0.98, as opposed to selection on standing variation.
Assuming an additive model of selection, constant popula-
tion size of Ne ¼ 3,000, and a generation time of 29 years,
we estimated the age of c.1436C>T to be 3 ka (highest pos-
terior density [HPD] ¼ 1–23) with a strong selection coeffi-
cient of s ¼ 0.14 (HPD ¼ 0.02–0.30) (Figure S7). Selection
coefficients of such magnitude have rarely been reported
in humans before.24 To further explore the impact of Ne
on our estimates, we repeated the analysis with Ne ¼
5,000 and Ne ¼ 7,000, yielding qualitatively unchanged
results (Table S9). Note, however, that despite the fact
that weak selection coefficients can be ruled out by the
ABC approach (Figure S7), the method fails to constrain
the upper bound of selection strength, limiting the accu-The Americanracy of the age estimation. It is thus likely that the times
are underestimates of the true age of the mutation. Under
the assumption of a Poisson model and a star-like geneal-
ogy, a maximum-likelihood (ML) estimate for the TMRCA
for c.1436C>T resulted in slightly older age estimates,
but they were within the HPD interval of the ABCmethod.
Based on high and low mutation rates,25 these TMRCA esti-
mates were 6.7 ka (confidence interval [CI] ¼ 3–13 ka) and
13.3 ka (CI ¼ 6–26 ka), respectively, for a 58,084 bp region
surrounding c.1436C>T (Table S10). These independent
estimates of TMRCA further support strong selection with
the use of the diffusion approximation to the fixation
time of a selective sweep26 and are consistent with the
presence of the allele in the 4-ka-old Saqqaq genome and
its absence from older genomes. Overall, when ancient-
DNA evidence is combined with the ABC- and ML-based
estimates and a slower mutation rate is used, a TMRCA of
6–23 ka ago seems most plausible.Journal of Human Genetics 95, 584–589, November 6, 2014 587
Our results provide evidence that the c.1436C>T muta-
tion was the likely target of selection and drove the sweep
signal over the surrounding genomic region. Together with
the variant’s high frequency in the coastal populations in
Northeast Siberia, North America, and Greenland18,27
(Figure 2A), this finding suggests that the mutation might
have historically conveyed a selective advantage to popula-
tions in these regions. With agriculture being unsustain-
able in this part of the world as a result of its extremely
cold environment, these coastal populations mostly fed
on marine mammals for a high-fat diet rich in n-3 polye-
noic fatty acids.13,28 Such a diet would have led the popu-
lations to be in a permanent state of ketosis,13,29 where
metabolism is mainly ‘‘lipocentric’’ (ketone bodies, fatty
acids) rather than ‘‘glucocentric’’ (glucose), as found in a
high-carbohydrate diet.30 A lipocentric metabolism pro-
vides an efficient means of maintaining energy, which is
similar to the state experienced during starvation.13
CPT1A imports long-chain fatty acids intomitochondria
for use in fatty-acid oxidation. This helps to maintain en-
ergy homeostasis and normoglycemia when carbohydrate
intake is low.27 The extent to which the c.1436C>T muta-
tion contributes to disorders associated with CPT1 defi-
ciency, such as hypoketotic hypoglycemia and sudden
infant death syndrome, is still unclear. The derived allele
has been reported as being deleterious in both the homo-
zygous and the heterozygous state. Yet, its phenotypic
effect might depend upon many environmental factors,
e.g., feeding history, infection, and climate.13,27 It is
known that the mutation decreases fatty-acid oxidation
and ketogenesis, explaining its role in hypoketotic hypo-
glycemia.13,28 However, there is also evidence that the mu-
tation decreases the inhibitory effect of malonyl-CoA on
fatty-acid b-oxidation in mitochondria, thereby partially
compensating for the drop in ketogenesis associated with
reduced CPT1A activity.13,28 A study on Alaskan Yup’iks
also suggests that the c.1436C>T mutation might exert a
cardioprotective role through its association with elevated
levels of high-density lipoprotein cholesterol and reduced
adiposity.28 Moreover, the large amounts of n-3 polyenoic
fatty acids in the traditional diet of these aboriginal peo-
ples are known to increase the activity of CPT1A.13,28
In this context, the CPT1A-activity decrease due to the
c.1436C>T mutation could be protective against overpro-
duction of ketone bodies.13 These important metabolic
effects of CPT1A provide the basis of our hypothesis that
the c.1436C>T mutation might have conferred a meta-
bolic advantage for the Northeast Siberian populations in
dealing with their traditional high-fat diet. The deleterious
effect of the mutation might be explained by a change
from the traditional diet to a more carbohydrate-based
one or by recent cultural shifts and environmental
stressors such as fasting and pathogens.
In conclusion, CPT1A c.1436C>T joins the short list of
known human variants where ill health in present-day
populations is a likely consequence of the same variant’s
being selectively advantageous in the past. Compared588 The American Journal of Human Genetics 95, 584–589, Novembwith the sickle cell allele rs334 (associated with sickle
cell disease [MIM 603903] and malaria resistance [MIM
611162])31 or rs73885319, rs60910145, and rs71785313
in apolipoprotein L-I (APOL1 [MIM 603743], associated
with kidney disease [FSGS4 (MIM 612551)] and sleeping-
sickness resistance32), the c.1436C>T allele shares the
property of altering a protein sequence. However, unlike
the sickle cell allele, it does not represent an example of
heterozygous advantage but instead provides an advanta-
geous or disadvantageous effect dependent on the envi-
ronment. In this way, it extends the range of selective
forces contributing to current ill health beyond infectious
diseases. It illustrates the medical relevance of an evolu-
tionary understanding of our past and suggests that
evolutionary impacts on health might be more prevalent
than currently appreciated.Supplemental Data
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